Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Yahoo Finance Results

    2. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MRK. Over the last one-month, outflows of investor capital in ETFs holding MRK totaled ...

    3. Company News For Oct 11, 2017

      Zacks via Yahoo FinanceOct 11 13:46 PM

      Shares Barracuda Networks, Inc. CUDA gained 0.04% after posting second quarter 2018 revenues of $94 million, surpassing the Zacks Consensus Estimate of $93 million Merck & Co ...

      63.40-0.48 (-0.75%)

      at Mon, Oct 23, 2017, 4:00PM EDT - U.S. Markets open in 3 hrs 59 mins

      Pre Mkt 63.40 N/A (N/A%)

      Delayed Quote

      • Ask Price 64.28
      • Bid Price 63.28
      • P/E 34.33
      • 52 Wk. High 66.80
      • 52 Wk. Low 58.29
      • Mkt. Cap 172.91B
    4. Merck , known as MSD outside of the United States and Canada, today announced a collaboration with the American Liver Foundation to raise awareness among U.S. veterans about their increased risk for chronic hepatitis C virus infection.

    5. The pharmaceutical sector has been grabbing investors’ attention of late with the NYSE ARCA Pharmaceutical Index gaining 13.1% and the Large Cap Pharmaceuticals industry 20.7% year to date, ...

    6. Global $114 Bn Antibody Drugs Technologies and Markets, 2017-2022

      PR Newswire via Yahoo FinanceOct 11 13:00 PM

      DUBLIN , October 11, 2017 /PRNewswire/ -- The "Antibody Drugs: Technologies and Global Markets" report has been added to Research and Markets' offering. The Global Market for Antibody Drugs Should ...

    7. Seattle Genetics, Inc. SGEN announced that the FDA has granted Breakthrough Therapy Designation status to its lymphoma drug, Adcetris, as frontline treatment for advanced classical Hodgkin ...

    8. KalVista Pharma Wins Big on Merck Collaboration

      24/7 Wall St. via Yahoo FinanceOct 10 13:00 PM

      KalVista Pharmaceuticals Inc. (KALV) saw its shares absolutely explode early on Tuesday after it was announced that the firm would be collaborating with Merck & Co. Inc ...

    9. Seattle Genetics Begins Phase II Study of Cancer Candidate

      Zacks via Yahoo FinanceOct 11 14:29 PM

      Seattle Genetics, Inc. SGEN and Astellas Pharma Inc announced the initiation of a phase II study-EV-201 of enfortumab vedotin. The study will evaluate patients with locally advanced ...

    10. Merck Provides Update on Anacetrapib Development Program

      Business Wire via Yahoo FinanceOct 11 20:45 PM

      Merck , known as MSD outside the U.S. and Canada, today announced that the company will not submit applications for regulatory approval for anacetrapib, Merck’s investigational cholesteryl ester transfer protein inhibitor.

    11. DUBLIN , October 9, 2017 /PRNewswire/ -- The "mHealth App Market by Type (Fitness, Lifestyle Management, Nutrition & Diet, Women's Health, Healthcare Providers, Disease Management) and Segment Forecasts, ...

    1. Ads
      related to Merck & Co., Inc